Disclosures for "Measurement of Real-world Digital Mobility Outcomes in People With Various Levels of Multiple Sclerosis-related Disability"
-
Ms. Mittl has received research support from National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R25AI179582.
-
Dr. Silbermann has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Silbermann has received research support from VA.
-
Mr. Day has nothing to disclose.
-
Author has nothing to disclose
-
Mr. Pearson has received personal compensation for serving as an employee of Clario.
-
Dr. Hogan has received personal compensation for serving as an employee of Cabaletta Bio. Dr. Hogan has stock in Cabaletta Bio. Dr. Hogan has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Sowalsky has nothing to disclose.
-
Mr. El-Gohary has received personal compensation for serving as an employee of Clario.
-
The institution of Dr. Wooliscroft has received research support from National Institutes of Health.